Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 15, 2007 (Vol. 27, No. 20)

Advancing Cancer Vaccines

A Drug Class Almost Ready to Take Off

  • The cadre of speakers extolling the virtues of therapeutic cancer vaccines at the recent “World Vaccine Congress” in Lyon, France, included Vincent Brichard, M.D., Ph.D., vp, cancer immunotherapeutics, GlaxoSmithKline Biologicals (www.gsk-bio.com). “Many would say that therapeutic cancer vaccines have experienced 20 years of failure, but I would say it ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.